Article in D Magazine The Frisco Physician Growing Hypo-Allergenic Peanuts Ayass Bioscience made headlines during COVID with an advanced lab and has now turned its molecular medicine expertise to preventing [...]
If you're in search of answers regarding your specific medical condition and the best treatment options available for your unique physiology, you've found the right place. [...]
Using Transcriptome to Accurate Disease Diagnosis, Prognosis, Severity, Treatment, and Adverse Reaction Prediction The identification of biomarkers plays a crucial role in assessing disease accuracy. Transcriptome biomarkers (gene expression [...]
Published: 30 December 2022 Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease Contributors: Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Victor Pashkov, [...]
The Texas State Health Department has confirmed the findings of a Ayass BioScience, LLC laboratory that detected two North Texas cases of the omicron variant.
Ayass BioScience, LLC has detected the first two cases of the OMICRON variant in the DFW Metroplex using Next Generation Sequencing (NGS). This is a part of our [...]
Dr. Ayass and Mass Spectrometry Scientist Wanying Cao, Ph.D. in front of "Nasopharyngeal Proteomic Findings in COVID-19 " Poster at the Annual 69th ASMS Conference on Mass Spectrometry.
Physician-scientists have changed the history of medicine by identifying problems in the clinic and taking to the laboratory to solve them. The founder of our company, Dr. Ayass, is revolutionizing [...]
Today, 4500 qualified life science industry influencers from around the globe participated in and attended over 450 presentations on Biotech Week Boston- a Workshop on Process Development and Manufacturing Scale [...]
Ayass Bioscience, LLC developed the FIRST APTAMER for the D-Dimer Test to Rule Out Suspected Pulmonary Embolism (PE), Deep Venous Thrombosis (DVT), Stroke, Disseminated Intravascular Coagulation (DIC)! Aptamers are molecules [...]
Polymorphisms in the Drug Transporter ABCB1, Potassium Channel KCNH2 and a1D-Adrenoceptor ADRA1D Domperidone is a better choice (compare to Metoclopramide) for treatment of Gastroparesis (symptomatic disorder of delayed gastric emptying) [...]
